Paysign (PAYS)
Runs prepaid payment programs for plasma centers, drugmakers, and healthcare clients.
$12.57
vs last close−0.35 (−2.67%)
Something off on this page? Send us feedback.
Next report
Nov 11, 26
in 49 days
EPS estimate
$0.09
Revenue estimate
$29.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
FY19FY20FY21FY22FY23FY24FY25FY26
Reported$0.14−$0.16−$0.06$0.02$0.11$0.07$0.13Pending
Estimate$0.20−$0.06$0.00$0.02$0.03$0.06$0.13$0.35
Surprise−30.7%−172.1%—−6.3%+244.9%+16.7%+2.0%—
RevenueReportedEstimate
FY19FY20FY21FY22FY23FY24FY25FY26
Reported$34.7M$24.1M$29.5M$38.0M$47.3M$58.4M$82.0MPending
Estimate$35.1M$24.3M$29.7M$38.2M$45.9M$58.2M$80.8M$114.7M
Surprise−1.2%−0.5%−0.8%−0.4%+2.9%+0.3%+1.5%—
HistoryUpcoming
| Fiscal year | Estimate | Reported | Surprise |
|---|---|---|---|
| 2027 | $0.42 | — | — |
| 2026 | $0.35 | — | — |
| 2025 | $0.13 | $0.13 | +2.0% |
| 2024 | |||
| 2023 | |||
| 2022 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
| 2018 | |||
| 2017 | |||
| 2016 |
| Fiscal year | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| 2027 | $0.42 | — | — | $133.2M | — | — |
| 2026 | $0.35 | — | — | $114.7M | — | — |
| 2025 | $0.13 | $0.13 | +2.0% | $80.8M | $82.0M | +1.5% |
| 2024 | ||||||
| 2023 | ||||||
| 2022 | ||||||
| 2021 | ||||||
| 2020 | ||||||
| 2019 | ||||||
| 2018 | ||||||
| 2017 | ||||||
| 2016 |